Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph P Kolb

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Immunity|February 18, 2016
Bon EPOtit! S1P-Mediated EPO Signaling Whets a Macrophage's Appetite for Apoptotic CellsJoseph P Kolb, Jennifer Martinez
Frontiers in Immunology|June 3, 2021
Glucocorticoids as Regulators of Macrophage-Mediated Tissue HomeostasisDavid Diaz-Jimenez, Joseph P Kolb, John A Cidlowski
Trends in Immunology|July 24, 2017
Programmed Cell Death and Inflammation: Winter Is ComingJoseph P Kolb, Thomas H Oguin, Andrew Oberst, et al.
Advances in Pharmacology (San Diego, Calif.)|February 26, 2013
Immunopharmacology of lipid A mimeticsWilliam S Bowen, Siva K Gandhapudi, Joseph P Kolb, et al.
Science Signaling|November 13, 2014
Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIFJoseph P Kolb, Carolyn R Casella, Shuvasree SenGupta, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2017
Galectin-3 directs antimicrobial guanylate binding proteins to vacuoles furnished with bacterial secretion systemsEric M Feeley, Danielle M Pilla-Moffett, Erin E Zwack, et al.
Immunity|January 13, 2019
The Nucleotide Sensor ZBP1 and Kinase RIPK3 Induce the Enzyme IRG1 to Promote an Antiviral Metabolic State in NeuronsBrian P Daniels, Sigal B Kofman, Julian R Smith, et al.
Cell Death and Differentiation|October 6, 2022
Correction: Global deletion of optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget's diseaseSing-Wai Wong, Bo-Wen Huang, Xiangxiang Hu, et al.
Cell Death and Differentiation|May 12, 2019
Global deletion of Optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget's diseaseSing-Wai Wong, Bo-Wen Huang, Xiangxiang Hu, et al.
Cell Death and Differentiation|July 18, 2020
Correction: Global deletion of optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget's diseaseSing-Wai Wong, Bo-Wen Huang, Xiangxiang Hu, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Immunity|February 18, 2016
Bon EPOtit! S1P-Mediated EPO Signaling Whets a Macrophage's Appetite for Apoptotic CellsJoseph P Kolb, Jennifer Martinez
Frontiers in Immunology|June 3, 2021
Glucocorticoids as Regulators of Macrophage-Mediated Tissue HomeostasisDavid Diaz-Jimenez, Joseph P Kolb, John A Cidlowski
Trends in Immunology|July 24, 2017
Programmed Cell Death and Inflammation: Winter Is ComingJoseph P Kolb, Thomas H Oguin, Andrew Oberst, et al.
Advances in Pharmacology (San Diego, Calif.)|February 26, 2013
Immunopharmacology of lipid A mimeticsWilliam S Bowen, Siva K Gandhapudi, Joseph P Kolb, et al.
Science Signaling|November 13, 2014
Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIFJoseph P Kolb, Carolyn R Casella, Shuvasree SenGupta, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2017
Galectin-3 directs antimicrobial guanylate binding proteins to vacuoles furnished with bacterial secretion systemsEric M Feeley, Danielle M Pilla-Moffett, Erin E Zwack, et al.
Immunity|January 13, 2019
The Nucleotide Sensor ZBP1 and Kinase RIPK3 Induce the Enzyme IRG1 to Promote an Antiviral Metabolic State in NeuronsBrian P Daniels, Sigal B Kofman, Julian R Smith, et al.
Cell Death and Differentiation|October 6, 2022
Correction: Global deletion of optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget's diseaseSing-Wai Wong, Bo-Wen Huang, Xiangxiang Hu, et al.
Cell Death and Differentiation|May 12, 2019
Global deletion of Optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget's diseaseSing-Wai Wong, Bo-Wen Huang, Xiangxiang Hu, et al.
Cell Death and Differentiation|July 18, 2020
Correction: Global deletion of optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget's diseaseSing-Wai Wong, Bo-Wen Huang, Xiangxiang Hu, et al.
Pageof 1